Phase II/III Study of an Alpha-1 Proteinase Inhibitor (Kamada-API) in Individuals With Alpha-1 Antitrypsin Deficiency

Clinical trial NCT00460096 · COMPLETED

Trial details

NCT number: NCT00460096
Sponsor: Kamada, Ltd.
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Alpha 1-Antitrypsin Deficiency

Start date: 2007-03-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.